Oragenics

Developer of novel treatments for infectious diseases and oral mucositis as well as probiotics for oral health

placeTampa, Florida, United States calendar_todayFounded 1996 groups5 employees language oragenics.com

Registered entities

Innovation

16 patent families (8 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace accelerating. Cited 804 times.

YearFilings
20128
20133
20142
20152
20162
20173
20182
20191
20201
20211
20242
20252

Social engagement

Social engagement: 1.9K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record.

Investor typeCountShare
Venture capital120%
Other / undisclosed480%

Recent activity

30 Jun 2026
Milestone
regulatory
17 Jun 2026
Product launch
intranasal platform
15 Jun 2026
Product launch
ONP-002
Coming soon